|
Volumn 30, Issue 2, 1998, Pages 516-517
|
Mycophenolate mofetil/tacrolimus/single-shot versus azathioprine/cyclosporine/ATG in pancreas-kidney transplantation: Results of a prospective randomized single-center study
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CEFOTAXIME;
CYCLOSPORIN;
CYTOMEGALOVIRUS ANTIBODY;
GANCICLOVIR;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
PREDNISOLONE;
STEROID;
TACROLIMUS;
THYMOCYTE ANTIBODY;
VANCOMYCIN;
ADULT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INSULIN DEPENDENT DIABETES MELLITUS;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY TRANSPLANTATION;
ORAL DRUG ADMINISTRATION;
PANCREAS TRANSPLANTATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
AZATHIOPRINE;
CYCLOSPORINE;
DIABETES MELLITUS, TYPE 1;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MUROMONAB-CD3;
MYCOPHENOLIC ACID;
PANCREAS TRANSPLANTATION;
PROSPECTIVE STUDIES;
TACROLIMUS;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0031956181
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(97)01383-3 Document Type: Conference Paper |
Times cited : (9)
|
References (8)
|